AnodyneWiki

Methamphetamine

MA
Methamphetamine
Salts
[]
Methamphetamine hydrochloride
Methamphetamine hydrochloride
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass149.23 g/mol [1]
Predicted LogP2.1 [1]
Structural Identifiers
[]
Molecular formulaC10H15N
IUPAC nameN-methyl-1-phenylpropan-2-amine
SMILESCC(CC1=CC=CC=C1)NC
InChIInChI=1S/C10H15N/c1-9(11-2)8-10-6-4-3-5-7-10/h3-7,9,11H,8H2,1-2H3
InChIKeyMYWUZJCMWCOHBA-UHFFFAOYSA-N
CAS number7632-10-2
UNII13ZT6YG5SD
PubChem CID1206
Pharmacokinetics[]
OnsetOral: 3 hours (peak), Intranasal: <15 minutes, Inhalation: <18 minutes, Intravenous: <15 minutes
Elimination half-life9–12 hours (range 5–30 hours); irrespective of route
Duration of action8–12 hours[3]
MetabolismCYP2D6 and FMO3[4]
ExcretionPrimarily kidney
Routes of administrationBy mouth, intravenous, intramuscular, subcutaneous, inhalation, insufflation, rectal, vaginal
Addiction liabilityVery high
Dosing[]
Insufflated
[]
Light≤ 15 mg(34x - 41.5%)
Common15 - 20 mg(13x - 15.9%)
Strong20 - 27.3 mg(14x - 17.1%)
Heavy27.3 - 31.8 mg(12x - 14.6%)
Extreme31.8 mg +(9x - 11.0%)
Intravenous
[]
Light≤ 56.2 mg(30x - 47.6%)
Common56.2 - 130 mg(2x - 3.2%)
Strong130 - 180 mg(22x - 34.9%)
Heavy180 - 200 mg(6x - 9.5%)
Extreme200 mg +(3x - 4.8%)
Oral
[]
Light≤ 20 mg(5x - 83.3%)
Common20 mg
Strong20 mg
Heavy20 - 22 mg
Extreme22 mg +(1x - 16.7%)
Intrarectal
[]
Light≤ 51.2 mg(4x - 57.1%)
Common51.2 mg
Strong40 - 200 mg(1x - 14.3%)
Heavy200 - 300 mg(2x - 28.6%)
Extreme300 mg +
Vaporized
[]
Light≤ 11.1 mg(12x - 57.1%)
Common11.1 mg
Strong10 - 25 mg(4x - 19.0%)
Heavy25 - 50 mg(4x - 19.0%)
Extreme50 mg +(1x - 4.8%)
Statistically derived dosages via DBI-IGS (archived by anodyne.wiki)
We do not take any responsibility for medical complications or loss of life sustained by following these dosages blindly.

Methamphetamine (also known as Anadrex, (2-Methylaminopropyl)benzene, (+-)-Methamphetamine, N,α-Dimethylbenzeneethanamine, Benzeneethanamine, N,α-dimethyl-, N-Methyl-1-phenyl-2-propylamine, α-Phenyl-β-methylaminopropane, Phenethylamine, N,α-dimethyl-, Brn 1072499 or 4-12-00-02589 (Beilstein Handbook Reference)) is a antidepressant, depressant and stimulant substance of the amphetamine class.

Chemistry

Salts []

Methamphetamine is typically found in the form of its hydrochloride salt.

 []

Methamphetamine is a racemic mixture of the (optical activity ( + / - )).

Stereoisomers from PubChem

Methamphetamine matches Lipinski's rule of five.

There are currently 12 reagent-interactions on

ReagentColor changeDescription
Marquisred-orange > brown
Meckeyellow
Mandelinslow (dark) green
Liebermannorange reddish
Froehdeclear or red
Robadopeno pink color change
Simon'sinstant dark blue
Ehrlichno color change
Hofmannno color change
Scottno color change
Morrispale green
Folinorange or pink

Pharmacology

Prodrugs of methamphetamine: Deprenyl, Dimethylamphetamine, Famprofazone.

Interactions []

Interaction mechanisms documented in (number of interacting drugs):

metabolism / inhibition / induction28 (5 contraindicated)
shared target27
shared target26
shared target1
shared target1
shared target1

Medical side effects []

19 side effects listed on drug labels in (methamphetamine).

  • Constipation
  • Diarrhoea
  • Dizziness
  • Headache
  • Hypersensitivity
  • Palpitations
  • Tachycardia
  • Tourette's disorder
  • Tremor
  • Urticaria
  • Agitation
  • Dyspepsia
  • Gastrointestinal disorder
  • Dysphoria
  • Euphoric mood
  • Erectile dysfunction
  • Psychotic disorder
  • Cardio-respiratory arrest
  • Insomnia

Indications

  • Attention deficit disorder
  • Distractibility
  • Electroencephalogram abnormal
  • Hyperkinesia
  • Learning disability
  • Mood swings
  • Obesity

Subjective effects []

0xea / Methamphetamine []
Routes:
  • Oral (10 - 50mg)
    Onset: ~ 35 m
    Duration: ~ 6 - 8 h
  • Insufflated (10 - 20mg)
  • Intrarectal (5 - 20mg)
  • Subcutaneous (4.2 - 15mg)
  • Intramuscular (10 - 15mg)
    Onset: 30 - 60 s
    Duration: ?
  • Intravenous (10 - 120mg)
    Onset: 10 - 15 s
    Duration: 1 - 8 h
  • Vaporized
Classes:Forms:
  • Hydrochloride
Source:
  • Crystal Meth: Goerlitzer park
Indication:Effects:After Effects:Tolerance:
  • builds steadily over the span of 1-2 weeks
  • sustained use leads to absolute tolerance where only adverse effects remain
a1ko / Methamphetamine []
Routes:
  • Insufflated
  • Smoked
  • Oral (145mg)
  • Intravenous (15 - 145mg)
  • Intramuscular
Effects:
bonzi / Methamphetamine []
Routes:
  • Oral (25mg)
Mere / Methamphetamine []
nervewing / Methamphetamine []
x86pup / Methamphetamine []
Routes:
  • Oral

Experience reports

Erowid

There are currently 30 experience reports involving methamphetamine on : []

Reddit

There are currently 50 trip reports involving methamphetamine on : []

 []

  • Australia: Methamphetamine is a Schedule 8.
  • Brazil: Methamphetamine is a F2.[5]
  • Canada: Methamphetamine is a Schedule I.
  • Germany: Methamphetamine is a Anlage II under the "Betäubungsmittelgesetz (BtMG)".
  • New Zealand: Methamphetamine is a Class A.
  • United Kingdom: Methamphetamine is a Class A under the "Misuse of Drugs Act 1971".
  • United States: Methamphetamine is a Schedule II under the "Controlled Substances Act".[6]
  • European Union: Methamphetamine is Prescription only.
  • United Nations: Methamphetamine is a Psychotropic Schedule II.
  • Other: Methamphetamine is a SE: Förteckning II.[7]

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 1206, Methamphetamine. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/1206
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Methamphetamine. UNII: 13ZT6YG5SD. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/13ZT6YG5SD
  3. Courtney KE, Ray LA. Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature. Drug Alcohol Depend. October 2014; 143():11–21. PMID 25176528.
  4. Sellers EM, Tyndale RF. Mimicking gene defects to treat drug dependence. Ann. N. Y. Acad. Sci. 2000; 909(1):233–246. PMID 10911933. https://doi.org/10.1111/j.1749-6632.2000.tb06685.x
  5. RDC Nº 804 – Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 24 July 2023. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-804-de-24-de-julho-de-2023-498447451
  6. Ingersoll J. Amphetamine, Methamphetamine, and Optical Isomers. Federal Register. 7 July 1971. https://archives.federalregister.gov/issue_slice/1971/7/7/12730-12734.pdf
  7. Desoxyn®, Tablett 5 mg. E-hälsomyndigheten. https://vara.ehalsomyndigheten.se/vara-web/visaProdukt.xhtml?id=20130603019155

Data sources []

SourceStatusUpdated (UTC)
dosingok2026-11-20 04:28:20
drugsprook2026-11-20 04:28:16
erowidok2026-11-20 04:28:25
gsrsok2026-11-20 04:28:18
hmdbmissing (hmdb.ca refused automated access to HMDB0251523)2026-11-20 04:28:16
keggok2026-11-20 04:28:18
pubchemok2026-11-20 04:28:14
redditok2026-11-20 04:28:16
siderok2026-11-20 04:28:16
structureok2026-11-20 04:28:16
wikipediaok2026-11-20 04:28:16